Clinical Trial Update: A Safety and Efficacy Study of NAC in Patients With TA-TMA [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NAC for thrombotic microangiopathy shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Thrombotic Microangiopathy

Drugs mentioned

• NAC

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Thrombotic Microangiopathies, Hematologic Diseases | Phase 3 | Status: COMPLETED | Results posted: 2022-02-14